European Journal of Gynaecological Oncology

European Journal of Gynaecological Oncology

Print ISSN: 0392-2936 | Online ISSN: 2709-0086

European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal. EJGO publishes on a broad range of gynaecologic oncology topics. Different types of articles are considered for publication (see Aims & Scope) with emphasis on original research to include prospective clinical trials, basic and applied science, case-control, and cohort studies. We also encourage the submission of systematic reviews and meta-analyses.


Articles

Open Access

Efficacy and safety of PARP inhibitors in advanced or recurrent endometrial cancer patients: a systematic review and single arm meta-analysis

Turkan Aliyeva,Hiba Siddique,Gustavo Meira Soares,Yumna Al Wraikat,Farah Mahzabin Hossain

DOI: 10.22514/ejgo.2026.021

Abstract ( 185 ) PDF (1.7 MB) ( 136 ) Full Text

Open Access

Real-world data on predictors of survival in patients with gynecological tumors following pelvic arterial embolization

Camila S. S. Menezes,Jesse L. da Silva,Lucas Z. de Albuquerque,Isabele A. Small,Hugo R. Gouveia,Henrique S. Martin,Jose H. M. Luz,Andreia C. de Melo

DOI: 10.22514/ejgo.2026.022

Abstract ( 176 ) PDF (7.81 MB) ( 144 ) Full Text

Open Access

Incidence and clinical course of lymphoceles following pelvic sentinel lymph node removal in endometrial cancer

Dor Meiroff,Michele Bollino,Barbara Geppert,Celine Lönnerfors

DOI: 10.22514/ejgo.2026.023

Abstract ( 178 ) PDF (302.01 kB) ( 137 ) Full Text

Open Access

Mismatch repair status in endometrial cancer: detection with immunohistochemical markers and its relationship with clinical outcome

Goncha Kamallı,Tuğçe Sırma,İsmet Hortu,Gürdeniz Serin,Mustafa Coşan Terek,Levent Akman

DOI: 10.22514/ejgo.2026.024

Abstract ( 170 ) PDF (3.02 MB) ( 107 ) Full Text

Open Access

Comparative outcomes of MPPE and segmental rectosigmoid resection in cytoreductive surgery for advanced ovarian cancer

Sahana Somasegar,Jiaqi Zhang,Talayeh Ghezelayagh,Simge Bagci Turkmen,Amer Karam

DOI: 10.22514/ejgo.2026.025

Abstract ( 167 ) PDF (494.3 kB) ( 127 ) Full Text

Open Access

OATH trial: a phase II trial evaluating the combination of onapristone with anastrozole for women with hormone receptor positive endometrial cancer

Ida Micaily,Mark S. Shahin,Mitchell I. Edelson,Norman G. Rosenblum,Ashley Douglas,Saveri Bhattacharya,Tommy Buchanan,Tingting Zhan,Tarek Sahmoud,Elizabeth R. Burton,Avnish Bhati,Russell J. Schilder

DOI: 10.22514/ejgo.2026.026

Abstract ( 189 ) PDF (1.07 MB) ( 103 ) Full Text

Open Access

p53 protein expression, TP53 gene mutations, and in silico p53 activity as prognostic markers for ovarian cancer

Estrid Høgdall,Tim Svenstrup Poulsen,Ib Jarle Christensen,Claus Høgdall

DOI: 10.22514/ejgo.2026.028

Abstract ( 191 ) PDF (2.33 MB) ( 124 ) Full Text

Open Access

Breast cancer: is the current screening appropriate?The RISCAM study

Maria Inês Leal,Ana Beatriz Silva,Sónia Torres,Daniela Bento,Deolinda Chaves Beça,António Luz Pereira

DOI: 10.22514/ejgo.2026.029

Abstract ( 197 ) PDF (4.61 MB) ( 113 ) Full Text

Open Access

Enhanced recovery after surgery (ERAS) for laparoscopic hysterectomy in low-risk endometrial cancer: a randomized controlled trial

Laura Cánovas-López,Iryna Kozak,Alberto Rafael Guijarro-Campillo,Carla Castañer,Luis Falcón-Araña,Julian J. Arense-Gonzalo,Francisco Barceló-Valcarcel,Victor Lago,Anibal Nieto,Marisa Sánchez-Ferrer

DOI: 10.22514/ejgo.2026.030

Abstract ( 163 ) PDF (850.2 kB) ( 142 ) Full Text

Open Access

Clinicopathological significance of immunohistochemical expression of p53 and PTEN in endometrial carcinoma

Chavdar Tsvetkov,Savelina Popovska,Krasimir Petrov

DOI: 10.22514/ejgo.2026.031

Abstract ( 169 ) PDF (1.97 MB) ( 109 ) Full Text

Open Access

Disease-free survival following total pelvic exenteration in localized platinum-resistant recurrent ovarian clear cell carcinoma: a case report

Norihito Kamo,Shu Soeda,Asami Kato,Chikako Okabe,Hideki Miura,Tetsu Sato,Yuta Endo,Shigenori Furukawa,Keiya Fujimori

DOI: 10.22514/ejgo.2026.033

Abstract ( 200 ) PDF (1.78 MB) ( 132 ) Full Text

Open Access

A case of complete uterine prolapse complicated by cervical squamous cell carcinoma likely unrelated to HPV

Naoki Horikawa,Saki Sawayama,Kaoru Fukae,Ryosuke Kuroda,Hikaru Kiyokawa,Ken Fukuhara

DOI: 10.22514/ejgo.2026.035

Abstract ( 177 ) PDF (624.53 kB) ( 138 ) Full Text

Open Access

Correction: PRDM6 promoter methylation as a potential epigenetic biomarker in BRCA-associated ovarian cancer

Numan Comert,Ozge Sukruoglu Erdogan,Betul Celik Demirbas,Seda Kilic Erciyas,Ahmet Dinc,Özge Pasin,Hülya Yazıcı,Seref Bugra Tuncer

DOI: 10.22514/ejgo.2026.036

Abstract ( 186 ) PDF (267.85 kB) ( 145 ) Full Text

Open Access

Correction: CpG methylation of the PAX1 promoter in exfoliated cervical cells: a potential cervical cancer screening model

Yu Chen,Yuanyuan Zhang,Xiaochun Chen,Hong Chu,Songqing Guan,Qiuni Liang,Yuting Xu,Xinyue Lv,Chunhua Li,Yun Li,Jin Liu,Wenlan Liu,Zhiying Yu

DOI: 10.22514/ejgo.2026.038

Abstract ( 211 ) PDF (247.35 kB) ( 113 ) Full Text

Open Access

Correction: Three serum miRNAs as potential biomarkers for early diagnosis of cervical cancer

Xiujuan Li,Xu Zhang,Minjie Zhang,Xiaojuan Luan,Diangeng Li,Meiling Jin,Xinyu Wen,Jingzhu Nan

DOI: 10.22514/ejgo.2026.039

Abstract ( 183 ) PDF (235.85 kB) ( 128 ) Full Text

Open Access

Correction: Prognostic value of Ki-67 in patients with ovarian cancer

Su Wan,Chang Su,Yong Wang,Jin Ding,Qingya Jiang,Huafeng Ding,Guantai Ni

DOI: 10.22514/ejgo.2026.040

Abstract ( 191 ) PDF (227.38 kB) ( 126 ) Full Text

Open Access

Correction: The cytotoxic, genotoxic and apoptotic effects of an adsorbent and anti‑oxidative vaginal gel on human cervical cancer cell (HeLa) lines

Gurkan Kiran,Eray Metin Guler,Abdurrahim Kocyigit,Ayse Filiz Gokmen Karasu,Norda Uckardes Katarmiyan,Fatma Basak Tanoglu

DOI: 10.22514/ejgo.2026.045

Abstract ( 179 ) PDF (218.13 kB) ( 146 ) Full Text

Open Access

Correction: Comparison of results of HPV infections and dysplastic changes of the uterine cervix in populations in Vojvodina (north region of Serbia) and Republic of North Macedonia

Verdi Stanojević,Aljoša Mandić,Nataša Nikolić,Slobodan Maričić,Goran Dimitrov,Bojana Gutić,Megi Mircevska,Branka Bašica

DOI: 10.22514/ejgo.2026.048

Abstract ( 174 ) PDF (434.53 kB) ( 128 ) Full Text

Open Access

Correction: FOXK2 affects the motility of endometrial cancer cells by mediating ZEB1

Gang Yu,Dong Ye,Fuqiang Gan,Xin Hu

DOI: 10.22514/ejgo.2026.052

Abstract ( 162 ) PDF (227.38 kB) ( 143 ) Full Text

Published Ahead of Print

Special Issues

Special issue title:

Contemporary surgical management of cervical cancer: minimally invasive surgery, de-escalation and personalized approaches

Keywords: Cervical cancer; Minimally invasive surgery; Robotic surgery; Fertility-sparing surgery; Personalized Surgical Treatment

Editor: Simone Ferrero, MD, PhD

Submission deadline: 30 June 2027

Special issue title:

Recent advances in gynecological oncology surgery

Keywords: Endometrial cancer; Ovarian cancer; Gynecology oncology; Surgery; IA; Cervical cancer; Vulvar cancer

Editor: Dr. Stefano Restaino, MD, Dr. Martina Arcieri, MD, PhD

Submission deadline: 28 February 2027

Special issue title:

Quality of Life in Gynecologic Malignancies

Keywords: Quality of life; Palliative care; Symptom management

Editor: Lori Spoozak, MD

Submission deadline: 30 April 2027

Special issue title:

Endometrial Cancer and Fertility Preservation in the Denatality ERA

Keywords: Endometrial cancer; Fertility preservation; Surgery fertility sparing; Ovarian reserve

Editor: Dr. Giuseppe Gullo, MD, PhD, Dr. Alessandra Lopez, MD, Dr. Valentina Billone, MD, PhD St.

Submission deadline: 31 December 2025

Special issue title:

Advances in Ovarian Cancer Research

Keywords: Ovarian cancer; Cytoreductive surgery; Recurrent ovarian cancer; Retroperitoneal lymphadenectomy; Women cancer global variation

Editor: Basel Refky, MD

Submission deadline: 31 October 2025

Special issue title:

Molecular Characterization in Endometrial Cancer: Progress and Prospects

Keywords: Endometrial Cancer (EC); Molecular Biomarkers; Immune Checkpoint Inhibitor; Precision Medicine

Editor: Andrea Giannini, MD, PhD

Submission deadline: 31 December 2022

Special issue title:

Immunotherapy for Gynecological Oncology

Keywords: Cancer immunotherapy;Cancer vaccination;Immune checkpoint inhibitor;Ovarian cancer;Cervical cancer;Endometrial cancer

Editor: Tadahiro Shoji, MD

Submission deadline: 31 July 2021

Special issue title:

Enhanced Recovery of Gynecological Oncology

Keywords: Gynecological Cancer; Enhanced Recovery After Surgery; Minimally Invasive Surgery; Pain Management; Nutritional Support; High Quality Nursing; Psychological Counseling; Complication Management

Editor: Lin Li, MD

Submission deadline: 31 December 2022

Special issue title:

Molecular Markers in Ovarian Cancer: Roles in Diagnosis, Prognostic Prediction, and Personalized Therapy

Keywords: Ovarian Cancer;Diagnosis;Prognosis;Treatment Response;Personalized Therapy;Platinum Resistance;Homologous Recombination Deficiency;Immunotherapy;Cytoreduction;Proteomics;Genomics;Prognostic Biomarkers;Diagnostic Biomarkers

Editor: Sharad Ghamande, MD, David Mysona, MD

Submission deadline: 30 March 2022

Special issue title:

Selected Papers from the 2021 AGOA Society

Keywords: Gynecology Oncology;Endometrial Cancer;Ovarian Cancer;Vulvar Cancer;Breast Cancer;Aragón

Editor: Laura Baquedano Mainar, MD

Submission deadline: 15 March 2022

To Be a Reviewer

If you would like to volunteer to review a manuscript for European Journal of Gynaecological Oncology journal, please click "Review for EJGO" below to register at our submission website or log in our Online Peer Review system. Your name, contact details, and expertise will be automatically added to our database of reviewers.


Review for EJGO

Join Editorial Board

You are welcome to join our editorial board. Our journal produces and issues editorial board certificates for editorial board members, and the journal website will display the names and personal websites of editorial board members to help enhance their scientific influence. Members of the editorial committee are entitled to 1 free publication (both editorial member's or recommended paper) per year, and other articles over 2 can enjoy 30% discount of publishing fee.


Join Editorial Board

Editor-in-Chief


Dennis S. Chi, MD, FACOG, FACS

Dr. Chi is the incumbent of the Ronald O. Perelman Chair in Gynecologic Surgery, Deputy Chief of the Gynecology Service, and Head of Ovarian Cancer Surgery at Memorial Sloan Kettering Cancer Center (MSKCC). He has been a faculty member at MSKCC since graduating from fellowship there in 1997. From 2001-2014, he was Co-Director of Pelvic Reconstructive Surgery and the Director of both the Gynecologic Oncology Fellowship and the Pelvic Reconstruction Clinical Research Fellowship. He established the International Gynecologic Oncology Fellowship program at MSKCC and was the Director of the program from 2004-2014. In 2014, he established the section of ovarian cancer surgery (named “Team Ovary”), the first gynecologic oncology team in the United States dedicated to improving the surgical and survival outcomes of patients with ovarian cancer. Since that time, Team Ovary has authored dozens of peer-reviewed publications and overall his research has led to over 370 peer-reviewed publications mostly focusing on surgery for gynecologic cancers. He is an editor of multiple textbooks and the lead editor of one of the authoritative textbook in the field of gynecologic oncology, Principles and Practice of Gynecologic Oncology, 8th edition. In March 2024, he was given the Society of Gynecologic Oncology’s Lifetime Achievement Award at their annual meeting.